Erin Colgan
2023
In 2023, Erin Colgan earned a total compensation of $734.2K as Former Chief Financial Officer at Sensei Biotherapeutics, a 14% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $162,134 |
|---|---|
| Option Awards | $99,554 |
| Salary | $423,667 |
| Stock Awards | $30,459 |
| Other | $18,388 |
| Total | $734,202 |
Colgan received $423.7K in salary, accounting for 58% of the total pay in 2023.
Colgan also received $162.1K in non-equity incentive plan, $99.6K in option awards, $30.5K in stock awards and $18.4K in other compensation.
Rankings
In 2023, Erin Colgan's compensation ranked 1,548th out of 2,983 executives tracked by ExecPay. In other words, Colgan earned more than 48.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,548 out of 2,983 | 48th |
Division Manufacturing | 908 out of 1,637 | 45th |
Major group Chemicals And Allied Products | 587 out of 906 | 35th |
Industry group Drugs | 571 out of 869 | 34th |
Industry Pharmaceutical Preparations | 406 out of 627 | 35th |
Source: SEC filing on April 29, 2024.
Colgan's colleagues
We found two more compensation records of executives who worked with Erin Colgan at Sensei Biotherapeutics in 2023.